Best healthcare team at the top 3 BBs in EMEA

Lucky enough to have received 2 SA offers from the top 3 BBs (JPM, MS, GS). As I have an interest in HC and given my background and the way I interviewed, I have strong chance to get that team at those 2 banks. I was wondering which of the 3 has the best healthcare team. Based mainly on deal flow, conversion, exit and prestige.

Is there really any material upside btween them or should one just go with the people they preferred.

I mainly interested in pharma/biotech if that matters.

Also interested in HC PE/GE or Emerging market PE or Activism HF.

Any advice would be very appreciated
Thanks

 

If you look at last years in EMEA I would say that JP/MS/BofA are doing great whilst GS is getting a little bit behind

Anyways BofA too focused on german market whilst the others are more diversified

My take from the 3 you listed would be JP if you are looking for a long career in the i HC

 

Hey man,

Could you send me a pm please. Cant seem to message you for some reason.

Im really keen on healthcare IB in LDN too due to my background as well and would love to ask you a few questions

 

Just personnal obsvervation but I feel like JPM is more prestigious than MS in EMEA and is better in terms of exits, can anyone confirm this? Pan European Monkey 

 

Seems like you got JPM and are trying to validate your choice. If you are confident that you can get placed into HC, then JPM wins.

But looking at overall reputation, prestige and exits, GS / MS is the clear choice

 

Doloribus consequatur animi facere doloremque ullam non occaecati beatae. Ratione tenetur sint quas perferendis cumque quae ad. Ullam eos ratione nesciunt vel cumque. Quam nesciunt alias quia tenetur optio facere. Non iure assumenda praesentium voluptatem officiis illo. Rem dolorum et magnam est eaque adipisci. Atque et ad fuga dicta maiores quasi quia.

Exercitationem optio quo quos ullam ut. Aut iusto esse exercitationem voluptatum culpa. Repellendus consequuntur eos quasi ut laboriosam enim. Numquam nulla voluptas libero incidunt voluptatem et praesentium.

Corporis eveniet odit qui excepturi. Minus perspiciatis veniam esse saepe aut neque. Et eum at saepe excepturi omnis commodi earum.

Optio ut quae qui temporibus alias omnis ea. Maxime ut molestiae ut. Consectetur repellat ut est sed ut autem natus.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
kanon's picture
kanon
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”